On the morning of July 20, 2023, Guo Yajuan, Deputy Minister of the Fourth Department of the National Drug Administration, led a team of 11 experts from the National Drug Administration, Jiangsu Provincial Bureau, Suzhou, and Kunshan drug regulatory departments to conduct on-site research and exchange on the key project of the China Drug Regulatory Science Action Plan, 'Research on Biological 3D Printing New Materials and Product Performance Evaluation Technology'.

As one of the key project participants,T-Bright Biotechnology introduced the research and development situation of the company's 3D printed medical device products, exchanged and reported on the problems encountered during the product development process and their solutions with leaders, and had in-depth discussions with experts on the performance evaluation methods of 3D printed medical device products.

The research team visited the company's product research and development laboratory, microbiological testing laboratory and clean production workshop, thanked the company for its reception work, highly praised the company's innovative product design ideas, unique production process routes and research achievements, and Hope Motor Company would continue to carry out technological innovation activities, accelerate the pace of product registration, and contribute to the technological progress of China's biological 3D printing medical devices.